_logo_256_384.jpg){kind=logo}
Healthcare | August 04, 2021
Illumina donates US $ I million in sequencing capabilities to BMC in Mumbai
It supports sequencing-based COVID 19 surveillance in India
It supports sequencing-based COVID 19 surveillance in India
Complementary business models are the reason for the acquisition
It works as an adjunct to standard care based on robust clinical trials
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
The company is confident of commencing production at both Mahad and Chiplun units soon
State-of-the-art R&D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides
As per the agreement, Lonza will provide commercial-scale manufacture of monoclonal antibodies
The distribution agreement is effective from 1 October 2021 and applies to Bormed products used in pharmaceutical packaging, medical and diagnostic devices
Ranitidine Hydrochloride is an important product for Solara and is manufactured at its Cuddalore site
Sun Pharma has committed Rs. 100 crores towards these initiatives
Subscribe To Our Newsletter & Stay Updated
